Our commitment to transforming 肾 care is focused on working with you to help achieve better outcomes for your patients as they sequence through their therapy journey; supporting the highest standards and access to care.
慢性肾脏疾病(CKD)是一个紧迫和日益增长的全球性挑战. We estimate there are as many as 4 million end-stage 肾 disease (ESRD) patients globally, and millions more people go undiagnosed; this is a situation projected to grow annually. 虽然你的患者人数在增长，但你的时间和成本资源并没有增加. We understand you need meaningful innovations and services that help you deliver better outcomes for more patients.
In the UK, there are an estimated 68,249 patients receiving Renal Replacement Therapy (RRT). Transplantation is the most common treatment modality (57%), haemodialysis (HD) is used in 35.腹膜透析(PD) 5例.6%的RRT患者. 在HD人群中，2%接受家庭血液透析(HHD)。.)1
60多年了, we have partnered with the nephrology community to focus on pioneering care in both haemodialysis (HD) and peritoneal dialysis (PD). We maintain that pioneering spirit today through new therapies like expanded haemodialysis (HDx) and remote patient management with Sharesource.
An increase in home therapies is widely regarded to be positive for both patients and healthcare professionals. Evidence exists that increasing levels of patient engagement can be clinically and economically effective2. Where patients are encouraged to take an active role as a key player in protecting their health, 应对急性疾病发作和管理他们的慢性疾病, 患者体验和满意度提高.
十大网赌公平平台有两个住宿培训设施，支持患者自我护理. The Baxter Education Centre (BEC) helps teach NHS patients to successfully manage their home dialysis. Baxter在Kew的BEC South有超过20年的患者培训经验, 伦敦, 培训过2个以上,自2006年以来已有500名患者. BEC North in Swinton, Manchester opened in June 2018 being the second centre of its kind in the UK.
We help to expand access to care by providing technologies and services that support care in different locations (home and in-centre) and create efficiencies.
We look to simplify the logistics of therapy, which may reduce the burden of care on patients.
SHARESOURCE extends your reach by allowing visibility to home patients’ adherence patterns, 这可能允许更早的干预. 远程保健平台是全球唯一可用的双向技术, 用于肾脏护理, 这样你就可以在诊所远程监控和管理治疗, 其中包括远程更改病人的处方设置的能力. 患者可以使用SHARESOURCE自动PD系统. Those who use this may find they have more confidence in performing their therapy at home. When healthcare providers report an increase in pre-emptive patient consultations and APD prescription adjustments, this in turn can help reduce the potential for complications that can lead to hospitalisation. 这可能导致资源利用率的降低和并发症的相关成本. SHARESOURCE是我们的homchoice CLARIA APD系统的特色.
HOMECHOICE CLARIA Automated peritoneal dialysis (APD) system with the SHARESOURCE remote patient management platform has user-friendly features that help end-stage 肾 disease patients manage their home peritoneal dialysis (PD) therapy, 同时保持他们与医疗保健提供者的远程连接.
HDx enabled by THERANOVA is the latest Baxter dialysis therapy for patients with end-stage 肾 disease. THERANOVA透析器具有创新的膜, 它提供了一种扩展的血液透析治疗(HDx).
For safe and proper use of the HOMECHOICE CLARIA with SHARESOURCE Remote Patient Management platform and THERANOVA, 请参阅相应的使用说明, 操作手册或用户指南.